bluebird bio is developing innovative gene therapies for severe genetic disorders. bluebird bio has two later stage clinical products in development for childhood cerebral adrenoleukodystrophy (CCALD) and beta-thalassemia/sickle cell anemia, a world-class team and a broadly applicable gene therapy platform.